Literature DB >> 21200149

PACSIN 2 represses cellular migration through direct association with cyclin D1 but not its alternate splice form cyclin D1b.

Hui Meng1, Lifeng Tian, Jie Zhou, Zhiping Li, Xuanmao Jiao, Wayne W Li, Markus Plomann, Zhishun Xu, Michael P Lisanti, Chenguang Wang, Richard G Pestell.   

Abstract

Cyclin D1 overexpression is a common feature of many human malignancies. Genomic deletion analysis has demonstrated a key role for cyclin D1 in cellular proliferation, angiogenesis, and cellular migration. To investigate the mechanisms contributing to cyclin D1 functions, we purified cyclin D1a-associated complexes by affinity chromatography and identified the PACSIN 2 (protein kinase C and casein kinase substrate in neurons 2) protein by mass spectrometry. The PACSIN 2, but not the related PACSIN 1 and 3, directly bound wild-type cyclin D1 (cyclin D1a) at the carboxyl terminus, and failed to bind cyclin D1b, the alternative splicing variant of cyclin D1. PACSIN 2 knockdown induced cellular migration and reduced cell spreading in LNCaP cells expressing cyclin D1a. In cyclin D1(-/-) mouse embryonic fibroblasts (MEFs), cyclin D1a, but not cyclin D1b, reduced the cell spreading to a polarized morphology. siPACSIN 2 had no effect on cellular migration of cyclin D1(-/-) MEFs. Cyclin D1a restored the migratory ability of cyclin D1(-/-) MEFs, which was further enhanced by knocking down PACSIN 2 with siRNA. The cyclin D1-associated protein, PACSIN 2, regulates cell spreading and migration, which are dependent on cyclin D1 expression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21200149      PMCID: PMC3048077          DOI: 10.4161/cc.10.1.14243

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  46 in total

1.  Active cdk6 complexes are predominantly nuclear and represent only a minority of the cdk6 in T cells.

Authors:  D Mahony; D A Parry; E Lees
Journal:  Oncogene       Date:  1998-02-05       Impact factor: 9.867

2.  New functional activities for the p21 family of CDK inhibitors.

Authors:  J LaBaer; M D Garrett; L F Stevenson; J M Slingerland; C Sandhu; H S Chou; A Fattaey; E Harlow
Journal:  Genes Dev       Date:  1997-04-01       Impact factor: 11.361

Review 3.  Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: analysis of allele-specific expression.

Authors:  Y Hosokawa; A Arnold
Journal:  Genes Chromosomes Cancer       Date:  1998-05       Impact factor: 5.006

4.  Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1).

Authors:  M Cheng; V Sexl; C J Sherr; M F Roussel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

5.  Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4.

Authors:  L Stepanova; X Leng; S B Parker; J W Harper
Journal:  Genes Dev       Date:  1996-06-15       Impact factor: 11.361

Review 6.  Cancer cell cycles.

Authors:  C J Sherr
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

7.  Cyclin D1 genetic heterozygosity regulates colonic epithelial cell differentiation and tumor number in ApcMin mice.

Authors:  James Hulit; Chenguang Wang; Zhiping Li; Chris Albanese; Mahadev Rao; Dolores Di Vizio; Salimuddin Shah; Stephen W Byers; Radma Mahmood; Leonard H Augenlicht; Robert Russell; Richard G Pestell
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

8.  Syndapin I, a synaptic dynamin-binding protein that associates with the neural Wiskott-Aldrich syndrome protein.

Authors:  B Qualmann; J Roos; P J DiGregorio; R B Kelly
Journal:  Mol Biol Cell       Date:  1999-02       Impact factor: 4.138

9.  Alternate splicing produces a novel cyclin D1 transcript.

Authors:  D C Betticher; N Thatcher; H J Altermatt; P Hoban; W D Ryder; J Heighway
Journal:  Oncogene       Date:  1995-09-07       Impact factor: 9.867

10.  Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase.

Authors:  J Y Kato; M Matsuoka; D K Strom; C J Sherr
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

View more
  27 in total

Review 1.  New roles of cyclin D1.

Authors:  Richard G Pestell
Journal:  Am J Pathol       Date:  2013-07       Impact factor: 4.307

2.  The cytoplasmic protein Pacsin 2 in kidney development and injury repair.

Authors:  Gang Yao; Annouck Luyten; Ayumi Takakura; Markus Plomann; Jing Zhou
Journal:  Kidney Int       Date:  2012-12-12       Impact factor: 10.612

Review 3.  Low-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted Therapies.

Authors:  Joseph A Caruso; Mylinh T Duong; Jason P W Carey; Kelly K Hunt; Khandan Keyomarsi
Journal:  Cancer Res       Date:  2018-09-07       Impact factor: 12.701

4.  Polycystin-1 regulates actin cytoskeleton organization and directional cell migration through a novel PC1-Pacsin 2-N-Wasp complex.

Authors:  Gang Yao; Xuefeng Su; Vy Nguyen; Kristina Roberts; Xiaogang Li; Ayumi Takakura; Markus Plomann; Jing Zhou
Journal:  Hum Mol Genet       Date:  2014-01-02       Impact factor: 6.150

5.  Sirt1-deficient mice have hypogonadotropic hypogonadism due to defective GnRH neuronal migration.

Authors:  Gabriele Di Sante; Liping Wang; Chenguang Wang; Xuanmiao Jiao; Mathew C Casimiro; Ke Chen; Timothy G Pestell; Ismail Yaman; Agnese Di Rocco; Xin Sun; Yoshiyuki Horio; Michael J Powell; Xiaohong He; Michael W McBurney; Richard G Pestell
Journal:  Mol Endocrinol       Date:  2014-12-29

6.  PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity.

Authors:  Gabriele Stocco; Wenjian Yang; Kristine R Crews; William E Thierfelder; Giuliana Decorti; Margherita Londero; Raffaella Franca; Marco Rabusin; Maria Grazia Valsecchi; Deqing Pei; Cheng Cheng; Steven W Paugh; Laura B Ramsey; Barthelemy Diouf; Joseph Robert McCorkle; Terreia S Jones; Ching-Hon Pui; Mary V Relling; William E Evans
Journal:  Hum Mol Genet       Date:  2012-07-30       Impact factor: 6.150

7.  Cyclin d1 downregulation contributes to anticancer effect of isorhapontigenin on human bladder cancer cells.

Authors:  Yong Fang; Zipeng Cao; Qi Hou; Chen Ma; Chunsuo Yao; Jingxia Li; Xue-Ru Wu; Chuanshu Huang
Journal:  Mol Cancer Ther       Date:  2013-05-30       Impact factor: 6.261

8.  Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.

Authors:  Hui Zhang; Tao Liu; Zhen Zhang; Samuel H Payne; Bai Zhang; Jason E McDermott; Jian-Ying Zhou; Vladislav A Petyuk; Li Chen; Debjit Ray; Shisheng Sun; Feng Yang; Lijun Chen; Jing Wang; Punit Shah; Seong Won Cha; Paul Aiyetan; Sunghee Woo; Yuan Tian; Marina A Gritsenko; Therese R Clauss; Caitlin Choi; Matthew E Monroe; Stefani Thomas; Song Nie; Chaochao Wu; Ronald J Moore; Kun-Hsing Yu; David L Tabb; David Fenyö; Vineet Bafna; Yue Wang; Henry Rodriguez; Emily S Boja; Tara Hiltke; Robert C Rivers; Lori Sokoll; Heng Zhu; Ie-Ming Shih; Leslie Cope; Akhilesh Pandey; Bing Zhang; Michael P Snyder; Douglas A Levine; Richard D Smith; Daniel W Chan; Karin D Rodland
Journal:  Cell       Date:  2016-06-29       Impact factor: 41.582

Review 9.  The double dealing of cyclin D1.

Authors:  Guergana Tchakarska; Brigitte Sola
Journal:  Cell Cycle       Date:  2019-12-29       Impact factor: 4.534

10.  PACSIN2 Interacts with Nonstructural Protein 5A and Regulates Hepatitis C Virus Assembly.

Authors:  Lap P Nguyen; Si C Tran; Shiro Suetsugu; Yun-Sook Lim; Soon B Hwang
Journal:  J Virol       Date:  2020-02-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.